3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
67
Phase NA
65
Phase 1
36
Phase 1/2
28
Phase 3
20
Phase 2/3
3
Phase 4
2
Phase EARLY_PHASE1
1
Status
Unknown
3
Withdrawn
2
Completed
2
Recruiting
1
Enrolling by invitation
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Breast
1
Conditions
Multiple Myeloma
28
Breast Neoplasms
23
Neoplasms
21
Pancreatic Neoplasms
17
Glioma
17
Prostatic Neoplasms
16
Glioblastoma
16
Recurrence
14
Leukemia, Myeloid, Acute
14
Solid Tumor
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
12
Lymphoma, Non-Hodgkin
12
Brain Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
9
Lung Neoplasms
9
Triple Negative Breast Neoplasms
8
Melanoma
8
Lymphoma
8
Hematologic Neoplasms
8
Lymphoma, B-Cell
7
Colorectal Neoplasms
7
Polycystic Ovary Syndrome
6
Neoplasm Metastasis
6
Head and Neck Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Carcinoma, Hepatocellular
6
Advanced Solid Tumors
6
Sarcoma
5
Myelodysplastic Syndromes
5
Leukemia, Plasma Cell
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Recruiting
×
Esophageal Neoplasms
×
Clear all
NCT06645808
2025-12-29
VARTUTRACE
Var2 Pharmaceuticals
Phase EARLY_PHASE1
Recruiting
32 enrolled